Page 7 - Nasdaq Tech News Today

Benchmark reissued their buy rating on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a report issued on Friday, Benzinga reports. The firm currently has a $120.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued reports about the stock. Robert W. Baird cut their price target on shares of Bio-Techne […]

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 26,662 shares of the biotechnology company’s stock after acquiring an additional 129 shares during the quarter. […]

Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,662 shares of the biotechnology company’s stock after purchasing an additional 129 shares during […]

S&CO Inc. boosted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,350 shares of the biotechnology company’s stock after purchasing an additional 270 shares during the quarter. S&CO Inc.’s holdings in Bio-Techne were […]

Barclays PLC cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 30.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,243 shares of the biotechnology company’s stock after selling 60,285 shares during the period. Barclays PLC’s holdings […]

Picton Mahoney Asset Management cut its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 49.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,830 shares of the biotechnology company’s stock after selling 1,776 shares during the quarter. Picton Mahoney Asset […]

Barclays PLC cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 30.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 137,243 shares of the biotechnology company’s stock after selling 60,285 shares during the quarter. Barclays PLC owned 0.09% of […]

Bio-Techne (NASDAQ:TECH – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Tuesday, August 8th. Analysts expect Bio-Techne to post earnings of $0.49 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Bio-Techne Price Performance […]

Amalgamated Bank reduced its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 5.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 57,553 shares of the biotechnology company’s stock after selling 3,185 shares during the quarter. Amalgamated Bank’s holdings in Bio-Techne […]

Fred Alger Management LLC boosted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 200.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,337,191 shares of the biotechnology company’s stock after purchasing an additional 892,681 shares during the period. Fred Alger Management LLC’s holdings in Bio-Techne were worth $110,826,000 at the […]